HSP110 as an adjuvant on the nanoparticle vaccine of cervical cancer can effectively prolong the survival rate of tumor-bearing mice
ZHANG Yue
TANG Jun
Machine-generated Keywords:
Publication Date:2018-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:9( 277-285 )
Immunological Journal

Immunological Journal

PKUISTIC
ISSN:1000-8861
Year, Vol.(Issue):2018,34(4)